DPHD from <i>Curcuma comosa</i> Enhances the Expansion and Osteogenic Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells While Attenuating Senescence

Osteoporosis and other degenerative bone disorders are major health burdens, and current therapies are limited in restoring bone regeneration. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) offer promise for regenerative medicine, but their clinical potential is restricted by replicative senescence during ex vivo expansion. In this study, we examined the effects of (3R)-1,7-diphenyl-(4E,6E)-4,6-heptadien-3-ol (DPHD), a diarylheptanoid derivative from Curcuma comosa Roxb, on hUC-MSC proliferation, senescence, migration, and osteogenic differentiation. Treatment with DPHD (2.5–5 μM) enhanced cell viability and proliferation while preserving MSC-specific marker expression and stemness-related genes (NANOG, OCT4, SOX2). DPHD significantly reduced senescence-associated β-galactosidase activity and reduced the expression levels of the cell cycle regulators p16 and p21, indicating an antisenescent effect. Moreover, DPHD suppressed the secretion of cytokines associated with the Senescence-Associated Secretory Phenotype (SASP), including IL-1β, IL-6, and MCP-1, and attenuated H2O2 induced ROS accumulation, confirming its antioxidant property. Furthermore, DPHD promoted osteogenic differentiation, as shown by increased ALP activity, calcium deposition, and upregulation of osteogenic marker genes. Mechanistically, DPHD upregulated Wnt/β-catenin-associated genes during proliferation (CTNNB1, C-MYC, AXIN2, CCND1) and enhanced osteogenic gene expression during differentiation (RUNX2, ALP, COL1A1), while inhibition of Wnt/β-catenin signaling suppressed these increases. Therefore, both the proliferative and osteogenic effects of DPHD are at least partly mediated through activation of the Wnt/β-catenin pathway. Collectively, these findings suggest that DPHD enhances the expansion and osteogenic potential of hUC-MSCs by attenuating cellular senescence while preserving their functional properties, underscoring its potential as a natural compound for improving MSC-based therapies in regenerative medicine.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-05-18
DOI
https://doi.org/10.1021/acsomega.5c08638
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DPHD from Curcuma comosa Enhances the Expansion and Osteogenic Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells While Attenuating Senescence

Chairat Tantrawatpan, Duangrat Tantikanlayaporn, Apichart Suksamrarn, Sirikul Manochantr et al.
ACS Omega
Mesenchymal stem cell research
article

DPHD from Curcuma comosa Enhances the Expansion and Osteogenic Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells While Attenuating Senescence

Chairat Tantrawatpan, Duangrat Tantikanlayaporn, Apichart Suksamrarn, Sirikul Manochantr, Waraluck Chaichompoo, Pakpoom Kheolamai, Nareerat Sutjarit, Nittaya Boonmuen, Moe Moe Paing
article en

Abstract

Osteoporosis and other degenerative bone disorders are major health burdens, and current therapies are limited in restoring bone regeneration. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) offer promise for regenerative medicine, but their clinical potential is restricted by replicative senescence during ex vivo expansion. In this study, we examined the effects of (3R)-1,7-diphenyl-(4E,6E)-4,6-heptadien-3-ol (DPHD), a diarylheptanoid derivative from Curcuma comosa Roxb, on hUC-MSC proliferation, senescence, migration, and osteogenic differentiation. Treatment with DPHD (2.5–5 μM) enhanced cell viability and proliferation while preserving MSC-specific marker expression and stemness-related genes (NANOG, OCT4, SOX2). DPHD significantly reduced senescence-associated β-galactosidase activity and reduced the expression levels of the cell cycle regulators p16 and p21, indicating an antisenescent effect. Moreover, DPHD suppressed the secretion of cytokines associated with the Senescence-Associated Secretory Phenotype (SASP), including IL-1β, IL-6, and MCP-1, and attenuated H2O2 induced ROS accumulation, confirming its antioxidant property. Furthermore, DPHD promoted osteogenic differentiation, as shown by increased ALP activity, calcium deposition, and upregulation of osteogenic marker genes. Mechanistically, DPHD upregulated Wnt/β-catenin-associated genes during proliferation (CTNNB1, C-MYC, AXIN2, CCND1) and enhanced osteogenic gene expression during differentiation (RUNX2, ALP, COL1A1), while inhibition of Wnt/β-catenin signaling suppressed these increases. Therefore, both the proliferative and osteogenic effects of DPHD are at least partly mediated through activation of the Wnt/β-catenin pathway. Collectively, these findings suggest that DPHD enhances the expansion and osteogenic potential of hUC-MSCs by attenuating cellular senescence while preserving their functional properties, underscoring its potential as a natural compound for improving MSC-based therapies in regenerative medicine.

ACS Omega
Thammasat University (TH), Mahidol University (TH), Center for Innovation (US), Ramathibodi Hospital (TH), Ramkhamhaeng University (TH)
Zero hunger
Openalex Percentile: Top 7%
Mesenchymal stem cell research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.